<VariationArchive VariationID="2680" VariationName="NM_031443.4(CCM2):c.23del (p.Gly8fs)" VariationType="Deletion" Accession="VCV000002680" Version="9" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17719" VariationID="2680">
      <GeneList>
        <Gene Symbol="CCM2" FullName="CCM2 scaffold protein" GeneID="83605" HGNC_ID="HGNC:21708" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="44999746" stop="45076470" display_start="44999746" display_stop="45076470" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="45039344" stop="45116068" display_start="45039344" display_stop="45116068" Strand="+" />
          </Location>
          <OMIM>607929</OMIM>
        </Gene>
        <Gene Symbol="LOC129998395" FullName="ATAC-STARR-seq lymphoblastoid silent region 18162" GeneID="129998395" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="45000148" stop="45000677" display_start="45000148" display_stop="45000677" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_031443.4(CCM2):c.23del (p.Gly8fs)</Name>
      <CanonicalSPDI>NC_000007.14:45000353:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="45000354" stop="45000354" display_start="45000354" display_stop="45000354" variantLength="1" positionVCF="45000353" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="45039953" stop="45039953" display_start="45039953" display_stop="45039953" variantLength="1" positionVCF="45039952" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>G8fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031443.3" sequenceAccession="NM_031443" sequenceVersion="3" change="c.23delG">
            <Expression>NM_031443.3:c.23delG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_664" sequenceAccession="LRG_664">
            <Expression>LRG_664:g.5169del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.45039955del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.45039955del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167935.2" sequenceAccession="NM_001167935" sequenceVersion="2" change="c.23del">
            <Expression>NM_001167935.2:c.23del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001161407.1" sequenceAccession="NP_001161407" sequenceVersion="1" change="p.Gly8fs">
            <Expression>NP_001161407.1:p.Gly8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363458.2" sequenceAccession="NM_001363458" sequenceVersion="2" change="c.23del">
            <Expression>NM_001363458.2:c.23del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350387.1" sequenceAccession="NP_001350387" sequenceVersion="1" change="p.Gly8fs">
            <Expression>NP_001350387.1:p.Gly8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363459.2" sequenceAccession="NM_001363459" sequenceVersion="2" change="c.23del">
            <Expression>NM_001363459.2:c.23del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350388.1" sequenceAccession="NP_001350388" sequenceVersion="1" change="p.Gly8fs">
            <Expression>NP_001350388.1:p.Gly8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031443.4" sequenceAccession="NM_031443" sequenceVersion="4" change="c.23del" MANESelect="true">
            <Expression>NM_031443.4:c.23del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_113631.1" sequenceAccession="NP_113631" sequenceVersion="1" change="p.Gly8fs">
            <Expression>NP_113631.1:p.Gly8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.45000356del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.45000356del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016295.1" sequenceAccession="NG_016295" sequenceVersion="1" change="g.5169del">
            <Expression>NG_016295.1:g.5169del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167934.2" sequenceAccession="NM_001167934" sequenceVersion="2" change="c.23del">
            <Expression>NM_001167934.2:c.23del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001161406.1" sequenceAccession="NP_001161406" sequenceVersion="1" change="p.Gly8fs">
            <Expression>NP_001161406.1:p.Gly8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="607929.0001" DB="OMIM" />
        <XRef Type="rs" ID="1562848466" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_031443.4(CCM2):c.23del (p.Gly8fs) AND Cerebral cavernous malformation 2" Accession="RCV000002799" Version="10">
        <ClassifiedConditionList TraitSetID="684">
          <ClassifiedCondition DB="MedGen" ID="C1864041">Cerebral cavernous malformation 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-22" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-22" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14624391</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18300272</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24689081</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="684" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="868" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cerebral cavernous malformations 2</ElementValue>
                <XRef ID="Cerebral+cavernous+malformations+2/7938" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cerebral cavernous malformation 2</ElementValue>
                <XRef ID="MONDO:0011304" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CCM2</ElementValue>
                <XRef Type="MIM" ID="603284" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cerebral cavernous malformations (CCMs) are vascular malformations in the brain and spinal cord comprising closely clustered, enlarged capillary channels (caverns) with a single layer of endothelium without mature vessel wall elements or normal intervening brain parenchyma. The diameter of CCMs ranges from a few millimeters to several centimeters. CCMs increase or decrease in size and increase in number over time. Hundreds of lesions may be identified, depending on the person's age and the quality and type of brain imaging used. Although CCMs have been reported in infants and children, the majority become evident between the second and fifth decades with findings such as seizures, focal neurologic deficits, nonspecific headaches, and cerebral hemorrhage. Up to 50% of individuals with FCCM remain symptom free throughout their lives. Cutaneous vascular lesions are found in 9% of those with familial cerebral cavernous malformations (FCCM; see Diagnosis/testing) and retinal vascular lesions in almost 5%.</Attribute>
                <XRef ID="NBK1293" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18313" />
                <XRef ID="18313" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301470</ID>
                <ID Source="BookShelf">NBK1293</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHA/ASA, 2014">
                <ID Source="PubMed">25355838</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="221061" DB="Orphanet" />
              <XRef ID="C1864041" DB="MedGen" />
              <XRef ID="MONDO:0011304" DB="MONDO" />
              <XRef Type="MIM" ID="603284" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="22957" SubmissionDate="2021-03-10" DateLastUpdated="2023-06-17" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607929.0001_CEREBRAL CAVERNOUS MALFORMATIONS 2" title="CCM2, 1-BP DEL, 23G_CEREBRAL CAVERNOUS MALFORMATIONS 2" />
        <ClinVarAccession Accession="SCV000022957" DateUpdated="2023-06-17" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family (family 2626) in which 4 members had type 2 cerebral cavernous malformations (CCM2; 603284), Liquori et al. (2003) found a heterozygous 1-bp deletion in exon 1 of the CCM2 gene (23delG), causing a frameshift at amino acid 23 and premature termination at amino acid 22.</Attribute>
              <Citation>
                <ID Source="PubMed">14624391</ID>
              </Citation>
              <XRef DB="OMIM" ID="603284" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CCM2" />
          </GeneList>
          <Name>CCM2, 1-BP DEL, 23G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 23G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607929.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CEREBRAL CAVERNOUS MALFORMATIONS 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3104086" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4868659|MedGen:C1864041" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001578486" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18300272</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24689081</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14624391</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Gly8Alafs*15) in the CCM2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CCM2 are known to be pathogenic (PMID: 18300272, 24689081). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with cerebral cavernous malformations (PMID: 14624391). It has also been observed to segregate with disease in related individuals. This variant is also known as 8fsX22. ClinVar contains an entry for this variant (Variation ID: 2680).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CCM2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.45039953del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1864041" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="22957" TraitType="Disease" MappingType="Name" MappingValue="CEREBRAL CAVERNOUS MALFORMATIONS 2" MappingRef="Preferred">
        <MedGen CUI="C1864041" Name="Cerebral cavernous malformation 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3104086" TraitType="Disease" MappingType="XRef" MappingValue="C1864041" MappingRef="MedGen">
        <MedGen CUI="C1864041" Name="Cerebral cavernous malformation 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

